Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
University of Washington
BeOne Medicines
Fred Hutchinson Cancer Center
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
University of Washington
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Fred Hutchinson Cancer Center
Ipsen
Genmab
Academic and Community Cancer Research United
University of Rochester
Altor BioScience
City of Hope Medical Center
City of Hope Medical Center
Stanford University
Mayo Clinic
University of Nebraska
University of Nebraska
Vanderbilt-Ingram Cancer Center
University of Nebraska
OHSU Knight Cancer Institute
TG Therapeutics, Inc.
Eastern Cooperative Oncology Group
University of Pennsylvania
Asana BioSciences
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Atara Biotherapeutics
Brown University
Fred Hutchinson Cancer Center
Medical College of Wisconsin
Medical College of Wisconsin
Mayo Clinic
Alexion Pharmaceuticals, Inc.
Medical College of Wisconsin
National Cancer Institute (NCI)
Spectrum Pharmaceuticals, Inc
Roswell Park Cancer Institute
ADC Therapeutics S.A.
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Gilead Sciences
Novartis